Yan Alsmeyer Email and Phone Number
Yan Alsmeyer work email
- Valid
- Valid
- Valid
- Valid
Yan Alsmeyer personal email
Yan Alsmeyer phone numbers
* Savvy and accomplished leader of drug development, highly regarded for orchestrating the development, commercialization, and manufacturing of pharmaceutical products. * Results-oriented individual who ensures aligned product vision while delivering superior guidance across product life cycle. * Produce the highest standards of quality and efficiency while championing comprehensive analytical rigor, flawless portfolio integration, and complete regulatory and quality compliance through effective CAPA and change controls.* Excellent communicator who synchronizes cross functional teams, builds key stakeholder relationships and enables cohesive global planning and execution.* Exceptional academic qualifications combined with 20+ years of experience serving in vital leadership roles for industry leaders including Gilead Sciences, Apotex, Upsher-Smith, and Pharmacia.Core Skills/Competencies:Pharmaceutical Development, Commercialization, Life Cycle Management, Cross-functional Team Leadership and Relationship, Technology Transfer, Complex Program and Portfolio Management, Continuous Process Verification, Method Development, Validation, Audit, Corrective and Preventative Action (CAPA); Change Control, Investigation, Quality Compliance, Outsourcing and Contract Partner Management, Global Product Registration, Operational Excellence
Apellis Pharmaceuticals
View- Website:
- apellis.com
- Employees:
- 783
-
Apellis PharmaceuticalsCalifornia, United States
-
Global Program Technical Operations Lead- CmcApellis Pharmaceuticals May 2021 - PresentWaltham, Ma, Us
-
Sr Director Of Analytical DevelopmentCorcept Therapeutics Jun 2017 - Apr 2021Redwood City, California, Us -
Director Of Analytical OperationsGilead Sciences Jun 2014 - Mar 2017Foster City, Ca, UsEstablished a commercial analytical operations team of 50 members in-house and 100+ dedicated FTEs at contract sites, focusing on quality control and stability testing in support of globally manufactured commercial bulk drug substances (APIs) and drug products (DPs). Negotiated supplier quality agreements to ensure high-quality standards and business needs achievement on time and within budget. Directed life cycle management of commercial test methods including method optimization, transfer, and additional validation to establish new manufacturing or testing sites for APIs and DPs.* Ensured timely delivery of API, a new chemical entity (NCE) and DP to meet market demands of a new oncology product and supported on-going clinical studies. Critically reviewed and secured successful global regulatory approvals.* Drove a refined risk-based selection, qualification, and requalification process for contract partners, and dramatically enhanced the process of independent API test result verification that significantly reduced incoming release testing of APIs at DP sites.* Led a cross-functional operational excellence corporate team, and designed/implemented an end-to-end automated technology solution to provide partners with Gilead product/process control information while tracking relevant partner implementation. * Critically reviewed numerous protocols and reports of various special studies in support of API and DP quality evaluation.* Created a tailored, statistically-based stability trending program to consolidate and effectively reduce stability studies for established commercial APIs and DPs by 50%.* Served as the focal point for commercial analytical operations and led the identification of deviations, design of CAPAs, and management of change controls for commercial products to ensure quality investigations. -
Director, Analytical DevelopmentApotex Inc. Nov 2011 - Jun 2014Toronto, Ontario, CaDirected a R&D staff of 80+ and report directly to the EVP in Product Development. Served as a key member of the corporate leadership team, responsible for full characterization of drug substances, reference listing drugs, and drug product development. Drug product dosage forms supported include capsules, tablets, and softgel capsule products of IR and various controlled release characteristics using technologies including hot melt, drug layering, tablet-in-tablet, tablet-in-capsule, controlled release coating, and hydrogel based matrix. This led to a significant number QbD based ANDA filings globally and new product launches annually. Provided leadership to establish quality target product profile (QTPP), evaluate API sourcing options, assess legal landscape, and perform preformulation and deformulation. Oversaw the development of physical, performance and analytical methods, method validation and transfer strategies. Set, justify, and defend specifications.Directed product development through full performance characterization of RLDs and Apotex development formulations using various dissolution conditions and biorelevant in vitro release profile target obtained using available in vivo PK data. Led RLD deformulation including API physical properties in the drug product matrix to guide the selection and control of API to be used in drug development. Provided critical guidance in IVIVC/IVIVR based justification for biowaiver or widening of dissolution specifications using WinNonlin. Led bilateral corporate partnership between Apotex and a major instrument companies. Spear-headed corporate laboratory automation technology. Led the corporate effort in establishing ICP-MS as an in-house capability and facilitate with API suppliers globally, and Apotex affiliates internally to devise and implement compliance strategies to USP, EP, and ICH Q3D requirements in finished products. -
Technical Director Of Discovery And Early Phase DevelopmentUpsher-Smith Laboratories Jun 2011 - Oct 2011Maple Grove, Mn, UsEstablished a new corporate department with internal competence and external capacity. Identified a team of consultants and contract research organizations to support Upsher-Smith early phase drug development to design, prepare lead and backup compounds, and scale-up selected compounds. Led the development of compound screening cascades, and directed compound screening to meet company key NDA program milestones. Represented early phase drug development in corporate due diligence efforts to evaluate in-license opportunities. Served on a corporate steering to incorporate the Stage Gate process in new product development.Led the corporate specification committee, review and approved specifications for all new and marketed products. -
Director Of Chemistry And Analytical SciencesUpsher-Smith Laboratories Jun 2009 - Jun 2011Maple Grove, Mn, UsResponsible for method development and validation, and stability programs in support of new product development of solid dose forms, semisolids, parental and nasal products. Led the department strategic planning and addressed gaps in capacities and capabilities,successfully recruited for and filled multiple strategic positions to support the corporate R&D strategy of becoming a semi-virtual NDA company. Represented the corporate in interactions with FDA on general GMP audits, PAIs, pre-IND, EOF-2, and pre-NDA face-to-face and telephone conferences and due diligence reviews of selecting potential new product and technology in-licensing opportunities. Led drug substance supplier selection process and performed over 60 supplier audit worldwide per ICH Q7. Set corporate strategies on extractable and leachable studies for the evaluation of container closure systems, in vitro release rate method development and validation using Franz-cell apparatus for semi-solid products, and CACO-2 studies for permeability to successfully secure BCS-based biowaiver for ANDAs.Established in-house preformulation capabilities. Implemented drug development phase appropriate method validation and refined document content templates to streamline and standardize method validation to support CTD regulatory submissions. Institutionalized QbD philosophies in product development, and led the development of technical guidelines for HPLC, Dissolution and GC method development and optimization. Established a corporate Metrology group. Provided the structure and discipline in the Metrology group for the centralization of instrument calibration and maintenance. Orchestrated and executed with precision a corporate physical relocation plan.
-
Director Of Analytical Research And DevelopmentUpsher-Smith Laboratories Mar 2003 - Jun 2009Maple Grove, Mn, Us
-
Principal Analytical Chemist/Analytical Team LeaderPharmacia Nov 2001 - Dec 2002New York, New York, Us -
Manager Of Analytical Chemistry Research LaboratoriesEastman Chemical Company Feb 1992 - Oct 2001Kingsport, Tennessee, Us
Yan Alsmeyer Skills
Yan Alsmeyer Education Details
-
The Ohio State UniversityChemistry -
Peking UniversityOrganic Chemistry
-
Peking UniversityOrganic Chemistry
Frequently Asked Questions about Yan Alsmeyer
What company does Yan Alsmeyer work for?
Yan Alsmeyer works for Apellis Pharmaceuticals
What is Yan Alsmeyer's role at the current company?
Yan Alsmeyer's current role is Program Director of Analytical Development at Corcept Therapeutics.
What is Yan Alsmeyer's email address?
Yan Alsmeyer's email address is ya****@****ept.com
What is Yan Alsmeyer's direct phone number?
Yan Alsmeyer's direct phone number is +165052*****
What schools did Yan Alsmeyer attend?
Yan Alsmeyer attended The Ohio State University, Peking University, Peking University.
What skills is Yan Alsmeyer known for?
Yan Alsmeyer has skills like Analytical Chemistry, Gmp, Pharmaceutical Industry, Chemistry, Technology Transfer, Hplc, Validation, Fda, Glp, Drug Development, Chromatography, Sop.
Who are Yan Alsmeyer's colleagues?
Yan Alsmeyer's colleagues are Javon Winston, Mba, Pacs, Ocsr, Becky (Rinard) Wolf, Kristen Kinghorn, Lesley Goodwin, Kathleen M. Doyle, Mba, Tracey Drake, Tara Barbour.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial